<DOC>
	<DOCNO>NCT00673231</DOCNO>
	<brief_summary>This study carry see Dapagliflozin addition insulin effective safe treat patient type 2 diabetes compare placebo ( identical look inactive treatment ) addition insulin</brief_summary>
	<brief_title>Efficacy Safety Dapagliflozin , Added Therapy Patients With Type 2 Diabetes With Inadequate Glycemic Control Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 2 Diabetes Patients HbA1c ≥7.5 % ≤10.5 % stable insulin regimen least 30 IU injectable insulin per day either without oral antidiabetic drug stable dose oral antidiabetic drug Type 1 Diabetes Treatment two additional oral antidiabetic drug Moderate severe renal ( kidney ) failure dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Dapagliflozin</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>add insulin</keyword>
	<keyword>Oral AntiDiabetic</keyword>
	<keyword>Type 2 diabetes</keyword>
</DOC>